If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Hydrogen system contract

3 Aug 2020 07:00

RNS Number : 8452U
TP Group PLC
03 August 2020
 

3 August 2020

 

TP Group plc

("TP Group", "the "Company" or the "Group")

Hydrogen system contract

TP Group (AIM: TPG), the providers of mission-critical solutions for a more secure world, is pleased to announce it has secured a contract worth approximately £1.0 million with a leading UK engineering company to provide management control equipment for enhanced safety management of hydrogen gas.

Under this contract, TP Group will qualify the design concepts, build and test a prototype system to manage hydrogen during emergency shutdown procedures more safely and reliably than existing methods.

Environments where explosive gas is present are classified into zones according to risk and are closely controlled. This innovative design uses combines TP Group's technologies with techniques that have been proven in other applications, which will be modified to perform in enclosed or containerised situations. The key objective is to respond quickly to a shutdown event, process the hydrogen and allow it to be vented safely in the controlled zone.

The project will start immediately at the TP Group facility in Portsmouth and is expected to be completed in mid-2021.

Phil Cartmell, Chief Executive Officer of TP Group, commented:

 

"We are very pleased to continue our work on mission-critical gas management systems with this existing key customer.

 

"These innovations build upon decades of experience producing highly reliable electrolyser-based solutions for demanding operational use, giving us the confidence that our solutions are well positioned for many years of future service. This contract is also highly complementary to other projects currently in development which leverage our expertise in innovative oxygen and hydrogen generation and management systems.

 

"The new approaches developed through this work apply in a wide range of critical applications where safe evacuation of hydrogen is needed. This opens up a range of potential uses in life support and renewable energy applications that the Group is actively pursuing."

 

 

For further information, please contact:

 

TP Group plc

Tel: 01753 285 810

Phil Cartmell, Chief Executive Officer

Derren Stroud, Chief Financial Officer

www.tpgroup.uk.com

Cenkos Securities plc

Tel: 020 7397 8980

Stephen Keys / Mark Connelly / Callum Davidson

www.cenkos.com

Vigo Communications

Tel: 020 7390 0230

Jeremy Garcia / Charlie Neish

www.vigocomms.com

 

 

Notes to Editors

 

TP Group delivers complex equipment, software and services for mission, business and safety critical applications in defence, space, intelligence & security and energy sectors. With more than 400 people in 6 European countries, it serves global customers through long-term contracts. The Group's shares have been traded on AIM since July 2001.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABLGDIUSGDGGB
Date   Source Headline
21st Nov 20228:51 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 20227:00 amRNSPublication of Scheme Document
17th Nov 20229:16 amRNSForm 8.5 (EPT/NON-RI)
16th Nov 20229:03 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
16th Nov 20228:33 amRNSForm 8.3 - TP Group PLC
14th Nov 20228:55 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20228:32 amRNSForm 8.3 - TP Group PLC
11th Nov 20228:18 amRNSForm 8.3 - TP Group PLC
10th Nov 20227:00 amRNSForm 8 (OPD) (TP Group plc)
7th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
4th Nov 202211:31 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
4th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
3rd Nov 202210:23 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
3rd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
2nd Nov 202211:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202210:44 amRNSForm 8 (DD) - TP Group plc
2nd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
1st Nov 20224:38 pmRNSForm 8.3 - TP Group Plc
1st Nov 202210:33 amRNSRule 2.10 - M&G Letter of Intent
1st Nov 20229:25 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
31st Oct 20225:22 pmRNSForm 8 (OPD) - TP Group plc
31st Oct 20227:00 amRNSRecommended Cash Aquisition of TP Group plc
31st Oct 20227:00 amRNSBusiness Update
26th Oct 20227:00 amRNSResignation of Auditor
27th Sep 20229:23 amRNSResult of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSPublication of Accounts
15th Aug 20227:00 amRNSAudited results for year ended 31 December 2021
12th Jul 20223:43 pmRNSCompletion of Disposal
28th Jun 20221:07 pmRNS2021 Financial Update
28th Jun 202210:43 amRNSResult of Annual General Meeting
21st Jun 202211:05 amRNSSecond Price Monitoring Extn
21st Jun 202211:00 amRNSPrice Monitoring Extension
20th Jun 20222:48 pmRNSExtension to Publication of Results
1st Jun 20221:27 pmRNSNotice of AGM and Accounts Update
26th May 20224:50 pmRNSSale of Sapienza Consulting Ltd.
1st Apr 20227:00 amRNSDisposal
31st Mar 20227:00 amRNSDirectorate Change
11th Feb 20227:00 amRNSBusiness Update
16th Dec 202110:30 amRNSCredit Facility to TP Group
16th Dec 202110:26 amRNSBusiness Update
1st Nov 20217:00 amRNSBusiness and Board Update
29th Oct 20215:00 pmRNSWithdrawal of GM Requisition - Replacement
29th Oct 20211:20 pmRNSWithdrawal of GM Requisition
29th Oct 202111:21 amRNSDirectorate Change
26th Oct 20211:15 pmRNSResponse re. Science Group Announcement
26th Oct 20217:00 amRNSRequisition of General Meeting of TP Group plc
14th Oct 20217:00 amRNSDirectorate Changes
11th Oct 20217:00 amRNSTrading and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.